发明授权
US08086308B2 Implantable medical device for identifying and managing intrinsic reentrant tachycardia 有权
用于识别和管理内在性折返性心动过速的植入式医疗装置

  • 专利标题: Implantable medical device for identifying and managing intrinsic reentrant tachycardia
  • 专利标题(中): 用于识别和管理内在性折返性心动过速的植入式医疗装置
  • 申请号: US12144351
    申请日: 2008-06-23
  • 公开(公告)号: US08086308B2
    公开(公告)日: 2011-12-27
  • 发明人: Paul A. Levine
  • 申请人: Paul A. Levine
  • 申请人地址: US CA Sylmar
  • 专利权人: Pacesetter, Inc.
  • 当前专利权人: Pacesetter, Inc.
  • 当前专利权人地址: US CA Sylmar
  • 主分类号: A61N1/18
  • IPC分类号: A61N1/18
Implantable medical device for identifying and managing intrinsic reentrant tachycardia
摘要:
An implantable medical device is provided that comprises a pulse generator that provides atrial and ventricular pacing pulses on demand. The pulse generator times delivery of the ventricular pacing pulses based on an AV pacing interval. The device also includes an AV hysteresis module that extends the AV interval from a base AV interval to an extended AV interval to promote intrinsic heart activity. A refractory module establishes a PVARP interval equal to base PVARP interval following at least one of the ventricular pacing pulses. The refractory module lengthens the PVARP interval by adding a PVARP extension to a base PVARP interval to provide an extended PVARP interval. The device further includes a reentrant conduction detector that identifies an intrinsic reentrant tachycardia having a retrograde P wave occurring during the PVARP extension, based on one or more of i) a retrograde P wave, ii) intrinsic R waves sensed over N cardiac cycles at an R to R interval above a rate threshold and iii) one or more of PR and RP intervals that exceed PR and RP thresholds.
信息查询
0/0